Digestive Enzyme Market Size - By Product (Lipases, Proteases, Carbohydrases [Amylases, Cellulase, lactases], Alpha-Galactosidase, (Maltase) (Protopectinase, Sucrases)), By Source (Animal, Microbial, Plant), By Application & Forecast, 2024-2032

Description

The Digestive Enzyme Market size will grow at 9.4% CAGR during 2024-2032, driven by the rising prevalence of digestive disorders. According to UZ Leuven, approximately 40% of the global population experiences chronic gastrointestinal issues. Conditions such as celiac disease, irritable bowel syndrome (IBS), and other gastrointestinal disorders are becoming increasingly common, prompting a heightened demand for digestive enzyme supplements. As more individuals seek relief from these conditions, there is a growing need for effective solutions that can aid digestion and alleviate symptoms. The consumer interest in supplements that offer targeted support and enhance digestive health is favoring market growth.

Nowadays, individuals are more informed about their digestive health. They are looking for targeted enzyme solutions that cater to specific conditions such as gluten sensitivity, and irritable bowel syndrome (IBS). Manufacturers are responding to this trend by developing specialized enzyme formulations. This includes enzymes that target the breakdown of specific carbohydrates, proteins, or fats, and those that are designed to support overall gut health. The innovations, alongside introduction of varied products, will bolster the market growth.

The digestive enzyme industry is classified based on product, source, application and region.

The maltase segment will gain significant traction through 2032, as it is crucial for proper carbohydrate digestion. The demand for maltase is rising due to its effectiveness in supporting digestive health, particularly for individuals with specific carbohydrate malabsorption issues. This growing interest in maltase reflects a broader trend towards targeted digestive enzyme solutions that cater to individual health needs.

The plant-based enzymes segment share will grow rapidly through 2032, owing to their natural origin and efficacy. These enzymes are known for their ability to aid digestion and reduce inflammation, making them a preferred choice for consumers seeking natural remedies. The shift towards plant-based sources is driven by a growing awareness of the benefits of plant-derived supplements and a rising demand for vegan and vegetarian options.

Asia Pacific digestive enzyme industry will grow at a decent pace through 2032, driven by increasing health awareness and rising disposable incomes. Countries such as China, India, and Japan are seeing a surge in the need for digestive supplements as more consumers become aware of their health benefits. The growing middle class in these countries is contributing to higher spending on health and wellness products, including digestive enzymes. Additionally, the increasing prevalence of digestive disorders and a shift towards preventive healthcare are fueling market growth in the region.

Product Code: 5346

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base size & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary sources
- 1.6.2 Data mining sources
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
- 3.1.1 Key manufacturers
- 3.1.2 Distributors
- 3.1.3 Profit margins across the industry
3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.2 Market challenges
- 3.2.3 Market opportunity
  - 3.2.3.1 New opportunities
  - 3.2.3.2 Growth potential analysis
3.3 Raw material landscape
- 3.3.1 Manufacturing trends
- 3.3.2 Technology evolution
3.4 Sustainable manufacturing
- 3.4.2 Sustainability in raw materials
3.5 Pricing trends (USD/Ton), 2021 to 2032
- 3.5.1 North America
- 3.5.2 Europe
- 3.5.3 Asia Pacific
- 3.5.4 Latin America
- 3.5.5 Middle East & Africa
3.6 Regulations & market impact
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
- 4.3.1 Company market share analysis by region
  - 4.3.1.1 North America
  - 4.3.1.2 Europe
  - 4.3.1.3 Asia Pacific
  - 4.3.1.4 Latin America
  - 4.3.1.5 Middle East Africa
4.4 Competitive positioning matrix
4.5 Strategic dashboard

Chapter 5 Market Size and Forecast, By Product, 2021-2032 (USD Million, Kilo Tons)

5.1 Key trends
5.2 Proteases
5.3 Lipases
5.4 Carbohydrases
5.5 Alpha-Galactosidase
5.6 Maltase
5.7 Others (Sucrases, Protopectinase, etc.)

Chapter 6 Market Size and Forecast, By Source, 2021-2032 (USD Million, Kilo Tons)

6.1 Key trends
6.2 Animal
6.3 Plant
6.4 Microbial

Chapter 7 Market Size and Forecast, By Application, 2021-2032 (USD Million, Kilo Tons)

7.1 Key trends
7.2 Human nutrition
- 7.2.1 Pharmaceuticals
- 7.2.2 Dietary supplements
  - 7.2.2.1 General nutrition
  - 7.2.2.2 Infant nutrition
  - 7.2.2.3 Sports nutrition
7.3 Animal nutrition
- 7.3.1 Poultry feed
  - 7.3.1.1 Broiler
  - 7.3.1.2 Layer
  - 7.3.1.3 Turkey
  - 7.3.1.4 Others
- 7.3.2 Swine
  - 7.3.2.1 Starter
  - 7.3.2.2 Grower
  - 7.3.2.3 Sow
- 7.3.3 Cattle feed
  - 7.3.3.1 Digestive
  - 7.3.3.2 Calf
  - 7.3.3.3 Others
- 7.3.4 Aquaculture
  - 7.3.4.1 Salmon
  - 7.3.4.2 Trout
  - 7.3.4.3 Shrimp
  - 7.3.4.4 Others
- 7.3.5 Pet Food
  - 7.3.5.1 Dogs
  - 7.3.5.2 Cats
  - 7.3.5.3 Birds
  - 7.3.5.4 Fish
- 7.3.6 Others

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 (Kilo Tons) (USD Million)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Russia
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 India
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 Australia
- 8.4.6 Malaysia
- 8.4.7 Indonesia
- 8.4.8 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 MEA
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 South Africa
- 8.6.4 Rest of MEA

Chapter 9 Company Profiles

9.1 DSM
9.2 Novozymes
9.3 AST Enzymes
9.4 Biotech Research Corporation
9.5 Abbott Corporation
9.6 Country Life LLC
9.7 Amway Corporation
9.8 Specialty Enzymes and Probiotics
9.9 Lumis Biotech
9.10 Amano Enzyme
9.11 Aumenzymes